Design of a Variant of Vascular Endothelial Growth Factor-A (VEGF-A) Antagonizing KDR/Flk-1 and Flt-1
- 1 April 2002
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (4) , 473-481
- https://doi.org/10.1038/labinvest.3780440
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Targetting VEGF in anti-angiogenic and anti-tumour therapy: Where are we now?International Journal of Experimental Pathology, 2002
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological ActivitiesJournal of Biological Chemistry, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGFBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Involvement of Loop 2 of Platelet-Derived Growth Faetor-AA and-BB in Receptor BindingGrowth Factors, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- A family of angiogenic peptidesNature, 1987
- Angiogenic FactorsScience, 1987